Celemics, Inc. (KOSDAQ:331920)
South Korea · Delayed Price · Currency is KRW 4,680.00
-5.00 (-0.11%)
At close: Feb 20, 2026
Celemics Market Cap
Celemics has a market cap or net worth of 38.21 billion as of February 20, 2026. Its market cap has increased by 36.24% in one year.
Market Cap
38.21B
Enterprise Value
31.73B
Revenue
6.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,680.00
Market Cap Chart
Since August 21, 2020, Celemics's market cap has decreased from 200.32B to 38.21B, a decrease of -80.93%. That is a compound annual growth rate of -25.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 38.21B | 72.38% |
| Dec 30, 2025 | 22.17B | -17.10% |
| Dec 30, 2024 | 26.74B | -22.58% |
| Dec 28, 2023 | 34.53B | -27.07% |
| Dec 29, 2022 | 47.35B | -62.21% |
| Dec 30, 2021 | 125.32B | -42.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| M.I.TECH Co.,Ltd | 239.16B |
| Synergy Innovation | 214.98B |
| BIOBIJOU | 191.82B |
| Corentec | 88.22B |
| DENTIS CO.,Ltd | 65.61B |
| Alpha AI | 40.31B |
| Finemedix | 39.59B |
| Genolution | 32.85B |